Great interview with Brent and long article on Rakon on the NBR this afternoon. Good messages delivered and good to see some effort in front footing this success. With EBITDA at say $44m when does this company deserve some bloody analyst coverage again??? There are so many loss making company and those making half the earnings of Rakon with coverage at the big investment banks. I obviously have a vested interest as a minor shareholder but I suggest to those shareholders with a relationship with say a Craigs or Jarden or whoever you mention to your contacts they should instate research coverage.